Antidepressant controlled trial for negative symptoms in schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.
<h4>Background</h4> <p>Negative symptoms of schizophrenia represent deficiencies in emotional responsiveness, motivation, socialisation, speech and movement. When persistent, they are held to account for much of the poor functional outcomes associated with schizophrenia. There are...
主要な著者: | Barnes, T, Leeson, V, Paton, C, Costelloe, C, Simon, J, Kiss, N, Osborn, D, Killaspy, H, Craig, T, Lewis, S, Keown, P, Ismail, S, Crawford, M, Baldwin, D, Lewis, G, Geddes, J, Kumar, M, Pathak, R, Taylor, S |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
National Institute for Health Research
2016
|
類似資料
-
Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial
著者:: Thomas RE Barnes, 等
出版事項: (2016-04-01) -
Long-term antidepressant treatment for negative symptoms in schizophrenia: the actions study
著者:: Barnes, T, 等
出版事項: (2017) -
Disclosing the potential impact of placebo controls in antidepressant trials
著者:: Stephanie C. Chen, 等
出版事項: (2015-06-01) -
Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness
著者:: Thomas RE Barnes, 等
出版事項: (2017-09-01) -
Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals.
著者:: Crawford, A, 等
出版事項: (2014)